Medical News

RSS

EMA COMP grants orphan medicinal product designation for Raptor's DR Cysteamine for cystinosis

Raptor Pharmaceutical Corp., announced that the European Medicines Agency's ("EMA") Committee for Orphan Medicinal Products ("COMP") has issued a positive opinion recommending orphan medicinal product designation for DR Cysteamine for the potential treatment of cystinosis.

15 Jun 2010

Orasi Medical signs agreement to study effect of Lundbeck CNS compounds on human brain

Orasi Medical today announced that it has entered an agreement with H. Lundbeck A/S to study the effect of Lundbeck central nervous system compounds on the human brain.

15 Jun 2010

Inovio commences immunization in U.S. Phase I clinical trial of SynCon H5N1 influenza DNA vaccine

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has immunized its first subject in a U.S. Phase I clinical trial to evaluate its SynCon™ H5N1 (avian) influenza DNA vaccine, VGX-3400X.

15 Jun 2010

UBC announces launch of new office in Lörrach, Germany

United BioSource Corporation today announced the launch of a new office in Lörrach, Germany, further expanding the company's clinical research and medical affairs capabilities in Europe. The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.

15 Jun 2010

SQNM first-quarter 2010 total revenues up 22%: MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring Sequenom Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

15 Jun 2010

Pieris commences PRS-050 anti-VEGF Anticalin Phase I clinical trial for cancer

Pieris AG announced today the initiation of a Phase I clinical trial in cancer patients for its lead program, PRS-050, an anti-VEGF Anticalin. The trial is an open-label, dose-escalating evaluation of the compound's safety and tolerability in patients with solid tumors. Conducted at three sites in Germany, the trial is underway and patients from the first cohort have been dosed.

15 Jun 2010

Cartoon moms combat obesity

Two Latina mothers are heroes in the new comic book, Small Changes Big Results from the Frances Payne Bolton School of Nursing at Case Western Reserve University. Their quest is to create a healthier lifestyle for their children and families and combat obesity.

15 Jun 2010

Project ideas needed from worldwide Alzheimer Disease research community

On the 9 June 2010, 119 participants from industry, academia, and related stakeholder communities in the U.S. and Europe joined Alzforum for a Webinar, "Treating Before Symptoms—ADCS Invites Ideas for Clinical Trials in Very Early AD," presented by Alzheimer's Disease Cooperative Study (ADCS) director Paul Aisen, MD.

15 Jun 2010

Best gift for Father's Day: CISRC

While Father's Day gifts range from the touching to the hilarious, the best gift you might give your father or spouse is help and support during the difficult time of a cancer diagnosis.

15 Jun 2010

Tips for correct application of sunscreen

You've gotten the message about the importance of sun protection, you're stocked up on sunscreen that's at least 15 SPF, and you're diligent about putting it on before you head outside. Once you've gotten this far, there's no reason to risk sunburns by applying it incorrectly. But, all too often, that's exactly what happens, says a Saint Louis University dermatologist.

15 Jun 2010

Researchers study how APOE4 becomes a potent risk factor for Alzheimer's disease

A molecule implicated in Alzheimer's disease interferes with brain cells by making them unable to "recycle" the surface receptors that respond to incoming signals, researchers at UT Southwestern Medical Center have found.

15 Jun 2010

ACRO unveils survey findings on decline in physician participation in clinical research

Today, the Association of Clinical Research Organizations (ACRO) unveiled findings from a groundbreaking survey exploring the decline in physician participation in clinical research across the United States and Western European markets at the 46th Drug Information Association (DIA) annual meeting. Over the past decade, the number of physicians participating in clinical research has continued to decrease in the U.S. and countries in Western Europe while participation increased at double digit rates in Asia, Latin America and Central/Eastern Europe.

15 Jun 2010

People's propensity to contribute to public good increases if contributions made public: Research

Public disclosure of companies' pollution habits has been an effective method of reducing pollution in many countries. Similarly, research has shown that people's and firms' propensity to contribute to public good increases if their contributions are made public. Findings from the University of Gothenburg reveal that the expected positive effect of disclosure can sometimes be crowded out by other factors at play.

15 Jun 2010

New regulation on 'grandfathered' health plans

The U.S. Departments of Health and Human Services, Labor and Treasury today issued a new regulation that makes good on President Obama's promise that Americans who like their health plan can keep it.

15 Jun 2010

Anytime Fitness expands to Japan

Anytime Fitness, the fastest-growing fitness club chain in the world, continues to accelerate its international expansion, this time – into Japan. The attainment of a master franchisee agreement for Japan, one year in the making, comes just weeks after the fitness chain announced its plans to open clubs in the United Kingdom and Ireland.

15 Jun 2010

First patient treated in multicentre Phase I clinical trial of SCIB1 DNA ImmunoBody vaccine for melanoma

Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, today announces the enrolment and treatment of the first patient in its multicentre Phase I clinical trial of SCIB1, its DNA ImmunoBody® vaccine being developed for the treatment of melanoma. The trial will evaluate the safety and tolerability of SCIB1 in patients with late stage melanoma.

15 Jun 2010

GE Healthcare unveils Centricity Advance SaaS solution for small, independent clinical practices

At a press unveiling this afternoon, GE Healthcare will demonstrate the newest addition to the Centricity® family of healthcare IT solutions, Centricity Advance.

15 Jun 2010

Billions spent yet millions live in poverty: Radical change needed in science, technology and innovation

Out-of-date innovation policy is undermining unprecedented opportunities for development aid to improve the environment and combat global poverty, according to a new Manifesto published today. We live in an era of rapid scientific advance yet poverty is deepening, the environment is in crisis and progress towards the Millennium Development Goals has stalled.

15 Jun 2010

University of Guelph student receives 2010 RHR Kendall Award

The Canadian Society for Industrial & Organizational Psychology recently announced that Stephen D. Risavy is the recipient of the 2010 RHR Kendall Award. Stephen is a Ph.D. candidate in the Industrial/Organizational Psychology program at the University of Guelph in Ontario. Sponsored by RHR International, a world leader in executive and organizational development, this award is presented for the best student paper of the year in Canadian I/O Psychology.

15 Jun 2010

Comprehensive source for treatment information of atrial fibrillation in the European market

Arlington Medical Resources, a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that electrical cardioversion usage patterns in Europe differed dramatically by country in the fourth quarter of 2009. While ECV represented almost half of all cardioversion attempts in Germany, in Spain ECV accounted for only 13% of cardioversion attempts.

15 Jun 2010

Medical News

EMA COMP grants orphan medicinal product designation for Raptor's DR Cysteamine for cystinosis

Orasi Medical signs agreement to study effect of Lundbeck CNS compounds on human brain

Inovio commences immunization in U.S. Phase I clinical trial of SynCon H5N1 influenza DNA vaccine

UBC announces launch of new office in Lörrach, Germany

SQNM first-quarter 2010 total revenues up 22%: MicroStockProfit.com

Pieris commences PRS-050 anti-VEGF Anticalin Phase I clinical trial for cancer

Cartoon moms combat obesity

Project ideas needed from worldwide Alzheimer Disease research community

Best gift for Father's Day: CISRC

Tips for correct application of sunscreen

Researchers study how APOE4 becomes a potent risk factor for Alzheimer's disease

ACRO unveils survey findings on decline in physician participation in clinical research

People's propensity to contribute to public good increases if contributions made public: Research

New regulation on 'grandfathered' health plans

Anytime Fitness expands to Japan

First patient treated in multicentre Phase I clinical trial of SCIB1 DNA ImmunoBody vaccine for melanoma

GE Healthcare unveils Centricity Advance SaaS solution for small, independent clinical practices

Billions spent yet millions live in poverty: Radical change needed in science, technology and innovation

University of Guelph student receives 2010 RHR Kendall Award

Comprehensive source for treatment information of atrial fibrillation in the European market

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News